Utah Medical Products, Inc.
UTMDNASDAQHealthcare● Active
$67.05
$-0.60(-0.89%)
Market Cap$213489212
P/E Ratio—
52W High$71.81
52W Low$52
Utah Medical Products, Inc. (UTMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
UTMD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 23, 2026EPS Actual
$0.82
Revenue
$0.01B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 23, 2026
After Market Close
UTMD reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | Apr 23, 2026 | — | $0.82 | — | $0.01B | — | — |
| — Q1 FY2026 | Jan 29, 2026 | — | $0.80 | — | $0.01B | — | — |
| — Q4 FY2025 | Oct 23, 2025 | — | $0.82 | — | $0.01B | — | — |
| — Q3 FY2025 | Jul 24, 2025 | — | $0.94 | — | $0.01B | — | — |
| — Q2 FY2025 | Apr 29, 2025 | — | $0.92 | — | $0.01B | — | — |
| — Q1 FY2025 | Mar 26, 2025 | — | $0.86 | — | $0.01B | — | — |
| — Q4 FY2024 | Oct 29, 2024 | — | $1.02 | — | $0.01B | — | — |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 23, 2026
EPS Actual
$0.82
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2026
Jan 29, 2026
EPS Actual
$0.80
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2025
Oct 23, 2025
EPS Actual
$0.82
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2025
Jul 24, 2025
EPS Actual
$0.94
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
Apr 29, 2025
EPS Actual
$0.92
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 26, 2025
EPS Actual
$0.86
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Oct 29, 2024
EPS Actual
$1.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 9 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 9 |
| Q1 FY2023 | $1.43 | $1.43 | $1.43 | 9 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 6 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 15 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 17 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 20 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 16 |
| Q1 FY2023 | $0.0B | $0.0B | $0.0B | 19 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 23, 2026 | — | $69.63 | $67.87 | -2.53% |
| — Q1 FY2026 | Jan 29, 2026 | — | $60.84 | $61.65 | +1.33% |
| — Q4 FY2025 | Oct 23, 2025 | — | $61.02 | $60.45 | -0.93% |
| — Q3 FY2025 | Jul 24, 2025 | — | $58.18 | $58.06 | -0.21% |
| — Q2 FY2025 | Apr 29, 2025 | — | $52.21 | $52.50 | +0.56% |
| — Q1 FY2025 | Mar 26, 2025 | — | $56.75 | $56.72 | -0.05% |
| — Q4 FY2024 | Oct 29, 2024 | — | $64.24 | $64.15 | -0.14% |
| — Q3 FY2024 | Jul 25, 2024 | — | $75.03 | $70.46 | -6.09% |
Q2 FY2026-2.53%
Report Date
Apr 23, 2026
EPS Beat/Miss
—
Price Before
$69.63
Price After
$67.87
Q1 FY2026+1.33%
Report Date
Jan 29, 2026
EPS Beat/Miss
—
Price Before
$60.84
Price After
$61.65
Q4 FY2025-0.93%
Report Date
Oct 23, 2025
EPS Beat/Miss
—
Price Before
$61.02
Price After
$60.45
Q3 FY2025-0.21%
Report Date
Jul 24, 2025
EPS Beat/Miss
—
Price Before
$58.18
Price After
$58.06
Q2 FY2025+0.56%
Report Date
Apr 29, 2025
EPS Beat/Miss
—
Price Before
$52.21
Price After
$52.50
Q1 FY2025-0.05%
Report Date
Mar 26, 2025
EPS Beat/Miss
—
Price Before
$56.75
Price After
$56.72
Q4 FY2024-0.14%
Report Date
Oct 29, 2024
EPS Beat/Miss
—
Price Before
$64.24
Price After
$64.15
Q3 FY2024-6.09%
Report Date
Jul 25, 2024
EPS Beat/Miss
—
Price Before
$75.03
Price After
$70.46
Beat Rate0 / 8 quarters
Largest Move-6.09% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: UTMD ends December
Utah Medical Products, Inc. (UTMD) most recently reported earnings on April 23, 2026 for Q2 FY2026, posting EPS of $0.82 (in line with the analyst consensus of —). The next UTMD earnings date is expected around September 1, 2026.
Each quarter, investors track UTMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. UTMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
UTMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
UTMD earnings · 4 questionsUtah Medical Products, Inc.'s next earnings report is expected around September 1, 2026. UTMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; UTMD historically reports after market close (AMC).
UTMD earnings datewhen is UTMD earningsUTMD next earnings datewhen does UTMD report earningsUTMD earnings calendar
▸ Source: FMP · Utah Medical Products, Inc. SEC filings · US GAAP · Utah Medical Products, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026